Key Takeaway: Ms. Amy Axel is a skilled scientist with a strong background in both academia and the pharmaceutical sector. She has worked at notable institutions such as Nationwide Children’s Hospital and Janssen/J&J, focusing on tumor microenvironments and biomarker strategies in clinical trials. Axel holds a BSc in Molecular Genetics from Ohio State University.
Price reaction · baseline $6.73 (2025-12-26 close) · 36 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%
Market Sentiment Analysis
POSITIVE FACTORS
Ms. Axel has extensive experience in both academia and the pharmaceutical industry.
She specializes in solid and hematologic tumors, contributing to significant research.
Her transition to operational roles highlights her adaptability and expertise.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor
Full Press Release Details
Ms. Axel is a highly skilled scientist with experience in academia (Nationwide Children’s Hospital, Ohio, USA) and the pharmaceutical industry (Janssen/J&J in Belgium and USA). She has expertise in solid and hematologic tumors focusing on physiologically relevant models for tumor microenvironment and complex cell‐based assays to evaluate molecules with varying mechanisms of action. Moving from directing hypothesis driven biomarker research projects, internally and externally, Ms Axel transitioned to an operational role at Janssen executing biomarker strategies in clinical trials in early development. She graduated from Ohio State University with a BSc. in Molecular Genetics.
Frequently Asked Questions
What is Amy Axel's educational background?
Amy Axel graduated with a BSc in Molecular Genetics from Ohio State University.
What experience does Amy Axel have in the pharmaceutical industry?
She has worked at Janssen/J&J, focusing on biomarker strategies in clinical trials.
What areas does Amy Axel specialize in?
Her expertise includes solid and hematologic tumors and tumor microenvironments.
Where did Amy Axel work in academia?
She worked at Nationwide Children’s Hospital in Ohio, USA.